Florida's skin cancer crisis deepens as older men face double the risk

Florida's skin cancer crisis deepens as older men face double the risk

Jeffrey Morgan
Jeffrey Morgan
2 Min.
Melanoma Rates and Mortality Peak Among Older Adults in Florida, Study Finds

Florida's skin cancer crisis deepens as older men face double the risk

A new study has highlighted the severe impact of skin cancer in Florida, particularly among older men. Researchers found that men in this age group face nearly double the mortality rate from the disease compared to women. The findings also reveal stark differences in risk between racial and ethnic communities across the state. Florida holds the unwelcome distinction of ranking second in the US for melanoma cases. The problem is especially acute among non-Hispanic white residents, who experience higher rates of the disease than Hispanic populations. Experts attribute this disparity partly to differences in sun exposure habits and access to healthcare.

The study noted a temporary decline in melanoma diagnoses in 2020, likely due to pandemic-related disruptions in healthcare services. However, cases rebounded sharply in 2021, returning to pre-pandemic levels. Researchers warn that Florida’s aging population—many with decades of cumulative sun exposure—faces growing vulnerability to the disease. Dr. Lea Sacca, the study’s senior author, stressed the need for stronger public health messaging aimed at older adults. She called for routine skin examinations and greater awareness of prevention methods. The report also recommends improved access to dermatologists and targeted campaigns to reduce risk factors. Melanoma remains largely preventable through behavioural changes and early treatment. Yet the study concludes that reducing its toll will require coordinated efforts, including better education and healthcare access for at-risk groups.

The research underscores the ongoing threat of melanoma in Florida, where aging residents and racial disparities worsen outcomes. Effective solutions will depend on evidence-based interventions, from public awareness drives to expanded specialist care. Without action, the state’s skin cancer burden is expected to keep rising.